Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (141-150 of 681) with videos related to

Pageof 69
Sort By:
Gynecologic Oncology|September 30, 2011
Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancerAmy E Bondurant, Zhiqing Huang, Regina S Whitaker, et al.
CA: a Cancer Journal for Clinicians|February 24, 2022
Genetic testing in prostate cancer management: Considerations informing primary careVeda N Giri, Todd M Morgan, David S Morris, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1994
Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cellsA Elbendary, A Berchuck, P Davis, et al.
The Permanente Journal|April 5, 2018
Naloxone Distribution and Training for Patients with High-Risk Opioid Use in a Veterans Affairs Community-Based Primary Care ClinicKatie E Raffel, Leila Y Beach, John Lin, et al.
American Journal of Obstetrics and Gynecology|March 1, 1991
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factorG C Rodriguez, A Berchuck, R S Whitaker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survivalJohnathan M Lancaster, Robyn Sayer, Carrie Blanchette, et al.
Obstetrics and Gynecology|March 1, 1994
The negative prognostic implications of thrombocytosis in women with stage IB cervical cancerG C Rodriguez, D L Clarke-Pearson, J T Soper, et al.
Gynecologic Oncology|March 1, 1995
Etoposide-platin combination therapy for chemorefractory gestational trophoblastic diseaseJ T Soper, A C Evans, G Rodriguez, et al.
The American Journal of Pathology|March 1, 1995
Distribution of integrin cell adhesion molecules in endometrial cancerB A Lessey, S Albelda, C A Buck, et al.
Obstetrics and Gynecology|January 1, 1994
Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic diseaseJ T Soper, A C Evans, D L Clarke-Pearson, et al.
Pageof 69

Showing results (141-150 of 681) with videos related to

Sort By:
Pageof 69
Gynecologic Oncology|September 30, 2011
Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancerAmy E Bondurant, Zhiqing Huang, Regina S Whitaker, et al.
CA: a Cancer Journal for Clinicians|February 24, 2022
Genetic testing in prostate cancer management: Considerations informing primary careVeda N Giri, Todd M Morgan, David S Morris, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1994
Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cellsA Elbendary, A Berchuck, P Davis, et al.
The Permanente Journal|April 5, 2018
Naloxone Distribution and Training for Patients with High-Risk Opioid Use in a Veterans Affairs Community-Based Primary Care ClinicKatie E Raffel, Leila Y Beach, John Lin, et al.
American Journal of Obstetrics and Gynecology|March 1, 1991
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factorG C Rodriguez, A Berchuck, R S Whitaker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survivalJohnathan M Lancaster, Robyn Sayer, Carrie Blanchette, et al.
Obstetrics and Gynecology|March 1, 1994
The negative prognostic implications of thrombocytosis in women with stage IB cervical cancerG C Rodriguez, D L Clarke-Pearson, J T Soper, et al.
Gynecologic Oncology|March 1, 1995
Etoposide-platin combination therapy for chemorefractory gestational trophoblastic diseaseJ T Soper, A C Evans, G Rodriguez, et al.
The American Journal of Pathology|March 1, 1995
Distribution of integrin cell adhesion molecules in endometrial cancerB A Lessey, S Albelda, C A Buck, et al.
Obstetrics and Gynecology|January 1, 1994
Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic diseaseJ T Soper, A C Evans, D L Clarke-Pearson, et al.
Pageof 69